Vocca Builds Healthcare AI for Patient Access
Vocca is building the administrative layer between a patient who needs care and the organization that has to route that request. Its voice and text agents answer calls, manage appointments, send reminders, and hand complicated cases to people, but the more important product sits behind the conversation: a scheduling engine designed around the rules of healthcare.
Co-founders Eliott Hoffenberg, CEO, and Hugo Danet, CTO, started the company in July 2024. Vocca now operates from Paris and New York. The company and its investors report that the platform serves 15,000 practitioners across 1,500 practices and more than 20 specialties in the United States and Europe.
That scale makes Vocca relevant beyond the voice AI category. The company is testing whether patient access can become software infrastructure without stripping away the exceptions, handoffs, and local policies that make healthcare scheduling difficult.
About Vocca
Vocca began with a familiar front-desk problem. Patients still rely heavily on the phone to reach a practice, while reception teams split their time between people standing in front of them and calls arriving from somewhere else. A missed call can mean a delayed visit, an unused appointment, or another administrative task waiting for the next shift.
Vocca's healthcare AI platform answers inbound calls around the clock and can place outbound calls for confirmations and reminders. It books, reschedules, and cancels appointments, responds to routine questions, and transfers urgent or complex cases to staff.
The system is not positioned as a replacement for clinical judgment. Its job is to complete repetitive administrative work and preserve the handoff when a person is required. That distinction matters in a market where conversational polish is easier to demonstrate than reliable execution.
The Scheduling Engine Behind the Voice
Healthcare booking is a rules problem disguised as a calendar. An appointment can depend on the examination, preparation instructions, practitioner qualifications, patient history, urgency, location, equipment, and the way a particular organization allocates its slots.
Vocca says its scheduling engine encodes those constraints across more than 20 specialties. It connects with more than 20 scheduling and patient-management systems so organizations can keep the software already embedded in their operations. A caller can speak naturally, but the platform still has to translate the request into the right action inside the correct system.
This is the company's strategic edge. A generic voice model can recognize a request. A healthcare workflow product has to know when to book, when to ask another question, when to propose a different slot, and when to escalate. The quality of that decision is what determines whether automation reduces work or simply creates a new review queue.
From Practices to Health Systems
Vocca and Norrsken VC report that the platform grew from 2,000 to 15,000 practitioners in one year. It now operates across 1,500 practices and handles more than one million patient conversations per month. The same sources report sevenfold revenue growth and a tenfold increase in conversation volume over the period.
The company says its agents complete 70% of conversations end to end without human involvement on average, rising above 85% among mature customers. Those are company- and investor-reported metrics, not an independently audited scorecard, but they clarify the operating model: automate the repeatable majority while preserving human control over exceptions.
Public customer examples span dental and ophthalmology groups, imaging centers, multidisciplinary practices, and hospitals. In April 2026, Vocca announced a deployment with the Adolphe de Rothschild Foundation Hospital in France. The range suggests that the addressable market is not one kind of clinic. It is the patient-access layer shared by organizations with very different workflows.
Leadership, Funding, and Expansion
Hoffenberg leads the commercial and company strategy as CEO, while Danet leads the technical organization as CTO. Their founding thesis connected the progress in voice AI with an operational area where delayed communication carries a real cost for patients and providers.
Vocca announced a $5.5M seed round in September 2025, led by Speedinvest and firstminute capital. In October 2026, Norrsken led a $20M Series A with participation from Heal Capital, Speedinvest, firstminute capital, and angels including founders of Alan and Datadog. The two disclosed rounds account for $25.5M in financing, although Vocca has not presented that sum as an official total.
The Series A is intended to deepen scheduling capabilities, add specialties and communication channels, and expand the company's US presence. No valuation was disclosed. The more useful signal is where the money is going: deeper workflow ownership rather than a broader claim to automate healthcare itself.
Reliability, Privacy, and the Edge Cases
Patient communication carries requirements that a general-purpose call bot does not face. A system may encounter sensitive information, urgent symptoms, language changes, specialty terminology, or a caller who wants a person. Every new integration and geography adds another set of edge cases.
Vocca's security documentation says the product is built for HIPAA and GDPR requirements, encrypts data in transit and at rest, and uses region-specific environments. It also says the company runs on infrastructure partners certified for SOC 2, ISO 27001, and HDS. That wording is important: the public evidence supports certified infrastructure, not a blanket claim that Vocca itself holds every certification.
For buyers, reliability will be measured in completed and correctly escalated tasks. A high automation rate only matters if it produces the right appointment, preserves the patient context, and gives staff a clear path back into the interaction.
Why Vocca's Hiring Momentum Matters
Vocca's careers page points to open work across the systems required to scale a vertical AI company. Current materials emphasize production AI reliability, evaluation, observability, integrations, implementation, product, and commercial expansion.
The company reportedly has about 40 people and plans to add roughly 40 more by year-end. That plan is best read as a demand signal, not recruiting copy. Scaling from practices into larger healthcare groups requires more than model development. It requires technical deployment, customer configuration, support, compliance, and local go-to-market work.
Vocca's challenge is to add that capacity without turning a configurable system into a collection of one-off implementations. The strongest version of the company will make specialty depth repeatable.
What Vocca Signals for Healthcare AI
The first major healthcare AI wave concentrated on work around the clinical encounter, especially documentation. Vocca represents a parallel shift toward patient-access infrastructure: the administrative work that determines whether a person reaches the right part of the system in the first place.
Voice is a useful interface because patients already know how to call. The defensible layer is the combination of scheduling logic, integrations, deployment knowledge, escalation design, and trust. Those pieces convert a conversation into a completed workflow.
Vocca's current growth suggests healthcare organizations are willing to buy that outcome. The next test is whether the company can preserve precision while expanding across specialties, channels, and the United States. If it does, the phone call becomes less of a queue and more of an entry point into healthcare operations.
Healthcare AI funding, last 30 days
DevCuration's funding database tracked 19 Healthcare AI rounds totaling $755.2M in disclosed capital over the past 30 days. Recent deals we covered:
- Vocca Raises $20M to Scale Healthcare Voice AI PlatformSeries A · $20M · Oct 6
- Parakeet Health Raises $10M to Scale Patient-Access AISeries A · $10M · Oct 2
- Redefine Surgery Closes Pre-Seed, Reaches $10M TotalPre-Seed · Sep 25
- Basalt Health Raises $20M Series A Led by NEA$20M · Sep 24
- UltraSight Raises $24M Series B2 for Cardiac Ultrasound AISeries B2 · $24M · Sep 23
Frequently Asked Questions
What does Vocca do?
Vocca provides healthcare voice and text agents that answer patient calls, manage bookings and reminders, handle routine requests, and transfer urgent or complex cases to staff. Its scheduling engine works with specialty rules and existing medical software.
Who founded Vocca?
Eliott Hoffenberg, Vocca's co-founder and CEO, and Hugo Danet, its co-founder and CTO, founded the company in July 2024.
Who uses Vocca?
Vocca and Norrsken VC report that the platform serves 15,000 practitioners across 1,500 practices and more than 20 specialties in the United States and Europe.
How much funding has Vocca raised?
Vocca announced a $5.5M seed round in September 2025 and a $20M Series A in October 2026. The two disclosed rounds add to $25.5M, although the company has not presented that figure as an official total.
Why does healthcare scheduling need specialized AI?
Healthcare appointments can depend on examination type, preparation, practitioner qualifications, urgency, location, and local scheduling policy. Specialized systems must apply those rules and escalate appropriately rather than only conduct a natural-sounding conversation.
Is Vocca hiring?
Vocca maintains an active careers page and has said it plans to expand its team as it deepens scheduling capabilities and grows in the United States. Candidates should check the live careers board for current roles.
Where the Money Moved
The intelligence briefing of the innovation economy. Funding, M&A, debt and fund closes, read as market signal rather than deal announcements.
Subscribe to Where the Money Moved